Literature DB >> 2777101

Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: 5 years follow-up.

P K Leaver1, B M Billington.   

Abstract

A series of 64 eyes, in 64 patients with giant retinal tears, treated by vitrectomy and fluid/silicone-oil exchange, has been reviewed after 5 years. Anatomical success was achieved in 73% of cases and visual function in successful cases ranged from 6/6 to NPL; 66% achieved acuities of 6/60 or better and 32% had vision of 6/18 or better. These results compare favourably with those in a previous series reported after 6 months and 18 months. Epiretinal membrane proliferation and shortening accounted for the majority of retinal redetachments while macular abnormalities, especially pucker, were responsible for a poor visual outcome. Glaucoma is the most serious long-term complication of the surgical method and occurs most frequently in aphakic eyes. Retention of the crystalline lens, whenever possible, the creation of a 6 o'clock iridectomy in aphakic eyes, early removal of silicone oil and a conservative approach to the use of scleral buckles are recommended.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777101     DOI: 10.1007/BF02169405

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Retinal tears 180 degrees and greater. Management with vitrectomy and intravitreal gas.

Authors:  R Machemer; A W Allen
Journal:  Arch Ophthalmol       Date:  1976-08

2.  Penetrating diathermy for retinal microincarceration in the management of giant retinal tears with inverted flaps.

Authors:  G W Kao; G A Peyman
Journal:  Retina       Date:  1986 Summer-Fall       Impact factor: 4.256

3.  Management of giant retinal tears without scleral buckling.

Authors:  M E Hoffman; E M Sorr
Journal:  Retina       Date:  1986       Impact factor: 4.256

4.  Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at six months.

Authors:  P K Leaver; R J Cooling; E B Feretis; J S Lean; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-06       Impact factor: 4.638

5.  Surgical treatment of giant retinal tears with inverted posterior retinal flaps.

Authors:  J Vidaurri-Leal; S de Bustros; R G Michels
Journal:  Am J Ophthalmol       Date:  1984-10-15       Impact factor: 5.258

6.  Use of liquid silicone in vitrectomised eyes.

Authors:  J D Scott
Journal:  Dev Ophthalmol       Date:  1981

7.  [Silicon oil injection for the treatment of complicated retinal detachment].

Authors:  H Laqua; M Herwig; A Wessing; G Meyer-Schwickerath
Journal:  Fortschr Ophthalmol       Date:  1982-11

8.  Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments.

Authors:  K H Lucke; M H Foerster; H Laqua
Journal:  Am J Ophthalmol       Date:  1987-12-15       Impact factor: 5.258

9.  Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at 18 months.

Authors:  B M Billington; P K Leaver
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

10.  [Silicone oil injection in the treatment of complicated retinal detachments].

Authors:  K Heimann; S Dimopoulos; H Paulmann
Journal:  Klin Monbl Augenheilkd       Date:  1984-12       Impact factor: 0.700

View more
  8 in total

1.  Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.

Authors:  Haote Han; Na Chen; Xionggao Huang; Bing Liu; Jingkui Tian; Hetian Lei
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

2.  The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells.

Authors:  Yajian Duan; Gaoen Ma; Xionggao Huang; Patricia A D'Amore; Feng Zhang; Hetian Lei
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

Review 3.  Management of Giant Retinal Tear Detachments.

Authors:  Maria H Berrocal; Megan L Chenworth; Luis A Acaba
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

4.  Silicone oil versus gas tamponade for giant retinal tear-associated fovea-sparing retinal detachment: a comparison of outcome.

Authors:  P J Banerjee; A Chandra; P Petrou; D G Charteris
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

5.  25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.

Authors:  John C Randolph; Rocio I Diaz; Eric J Sigler; Jorge I Calzada; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-12       Impact factor: 3.117

6.  Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.

Authors:  Gaoen Ma; Yajian Duan; Xionggao Huang; Cynthia X Qian; Yewlin Chee; Shizuo Mukai; Jing Cui; Arif Samad; Joanne Aiko Matsubara; Andrius Kazlauskas; Patricia A D'Amore; Shuyan Gu; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

7.  Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.

Authors:  Guohong Zhou; Yajiang Duan; Gaoen Ma; Wenyi Wu; Zhengping Hu; Na Chen; Yewlin Chee; Jing Cui; Arif Samad; Joanne A Matsubara; Shizuo Mukai; Patricia A D'Amore; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

8.  Giant retinal tears after prior pars plana vitrectomy: management strategies and outcomes.

Authors:  Marco A Gonzalez; Harry W Flynn; William E Smiddy; Thomas A Albini; Audina M Berrocal; Paul Tenzel
Journal:  Clin Ophthalmol       Date:  2013-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.